Friday, July 27, 2012

Arch Coal (NYSE: ACI) Jumps +20% After Solid Earnings Call

Arch Coal (NYSE: ACI) Jumps +20% After Solid Earnings CallTomahawk, WI 7/27/12 (StreetBeat) – Arch Coal, Inc. (NYSE: ACI) is up nearly 20 percent at $6.26 per share on heavy volume of nearly 20 million shares, as I write.

The company’s earnings call started at 11:00 am ET today and must have pleased investors.

Arch Coal’s stock is down quite a bit from its 52-week high of $26.50 per share in August of last year, but hopefully this is a sign of good things to come.

Arch Coal is a top five global coal producer and marketer. Arch is the most diversified American coal company, with mining complexes across every major U.S. coal supply basin. Its core business is supplying cleaner-burning, low-sulfur thermal and metallurgical coal to power generators and steel manufacturers on five continents.

StreetBeat Disclaimer

Distributed by Viestly

Arch Coal (NYSE: ACI) Jumps +20% After Solid Earnings Call

Arch Coal (NYSE: ACI) Jumps +20% After Solid Earnings CallTomahawk, WI 7/27/12 (StreetBeat) – Arch Coal, Inc. (NYSE: ACI) is up nearly 20 percent at $6.26 per share on heavy volume of nearly 20 million shares, as I write.

The company’s earnings call started at 11:00 am ET today and must have pleased investors.

Arch Coal’s stock is down quite a bit from its 52-week high of $26.50 per share in August of last year, but hopefully this is a sign of good things to come.

Arch Coal is a top five global coal producer and marketer. Arch is the most diversified American coal company, with mining complexes across every major U.S. coal supply basin. Its core business is supplying cleaner-burning, low-sulfur thermal and metallurgical coal to power generators and steel manufacturers on five continents.

StreetBeat Disclaimer

Distributed by Viestly

Thursday, July 26, 2012

Zynga (Nasdaq: ZNGA) is Withering on the Vine

Northern, WI 7/26/2012 (StreetBeat) -- Zynga is losing time, losing players and is losing share value to the tune of almost 40% in morning trading. See Full Disclaimer

Distributed by Viestly

3 Things to Consider While Trading Today

3 Things to Consider While Trading TodayTomahawk, WI 7/26/12 (StreetBeat) – *Stocks were mixed in Asian trade. The Nikkei rose 0.9% and Australia was up about 0.6%, but the Hang Seng was essentially flat and Shanghai fell a half percent. European markets all rallied this morning when the ECB boss gave a “whatever it takes” comment, in particular Spain and Italy are up three and four percent respectively. US stock futures also caught a bid after Draghi spoke and are now up about one percent.

*With the turn of a phrase ECB boss Draghi rallied stock markets everywhere and debt in the Euro Zone periphery. In the last couple of hours he said; “Within our mandate, the ECB is ready to do whatever it takes to preserve the euro, and believe me, it will be enough.” In his London speech he said the euro is irreversible and that one should not underestimate the political capital in the euro. Spanish and Italian debt yields have fallen sharply in the aftermath of the comments, but at the moment Spain’s 10 Year market is straddling seven percent.

*The June reading of Germany’s Import Price Index is -1.5% year on year, well below the estimate of -0.9%.

*The weekly report on Initial jobless claims is due out at 7:30am CDT, it is expected to be 380k. Also due out at 7:30am is the June reading of Durable Goods Orders. Headline Orders is expected to be up 0.3% month on month and Orders ex-transportation are forecast to be +0.1%. The June reading of Pending Home Sales is due out at 9:00am CDT, it is expected to be +0.3% on the month.

*The weekly report on inventories of Natural Gas is due out at 9:30am CDT, it is expected to show an increase of 26 bcf.

*The July reading of the Kansas City Fed Manufacturing Activity Index is due out at 10:00am CDT, it is expected to improve by one point on the month to 4.

*The Fed is scheduled to buy Treasuries today that are due to mature between 2/15/36 and 5/15/42; the results of the operation will be announced just after 10:00am CDT.

*The Treasury plans to sell $29 billion 7 Year Notes today; the auction results will be announced just after noon CDT.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Consider While Trading Today

3 Things to Consider While Trading TodayTomahawk, WI 7/26/12 (StreetBeat) – *Stocks were mixed in Asian trade. The Nikkei rose 0.9% and Australia was up about 0.6%, but the Hang Seng was essentially flat and Shanghai fell a half percent. European markets all rallied this morning when the ECB boss gave a “whatever it takes” comment, in particular Spain and Italy are up three and four percent respectively. US stock futures also caught a bid after Draghi spoke and are now up about one percent.

*With the turn of a phrase ECB boss Draghi rallied stock markets everywhere and debt in the Euro Zone periphery. In the last couple of hours he said; “Within our mandate, the ECB is ready to do whatever it takes to preserve the euro, and believe me, it will be enough.” In his London speech he said the euro is irreversible and that one should not underestimate the political capital in the euro. Spanish and Italian debt yields have fallen sharply in the aftermath of the comments, but at the moment Spain’s 10 Year market is straddling seven percent.

*The June reading of Germany’s Import Price Index is -1.5% year on year, well below the estimate of -0.9%.

*The weekly report on Initial jobless claims is due out at 7:30am CDT, it is expected to be 380k. Also due out at 7:30am is the June reading of Durable Goods Orders. Headline Orders is expected to be up 0.3% month on month and Orders ex-transportation are forecast to be +0.1%. The June reading of Pending Home Sales is due out at 9:00am CDT, it is expected to be +0.3% on the month.

*The weekly report on inventories of Natural Gas is due out at 9:30am CDT, it is expected to show an increase of 26 bcf.

*The July reading of the Kansas City Fed Manufacturing Activity Index is due out at 10:00am CDT, it is expected to improve by one point on the month to 4.

*The Fed is scheduled to buy Treasuries today that are due to mature between 2/15/36 and 5/15/42; the results of the operation will be announced just after 10:00am CDT.

*The Treasury plans to sell $29 billion 7 Year Notes today; the auction results will be announced just after noon CDT.

StreetBeat Disclaimer

Distributed by Viestly

Zynga (Nasdaq: ZNGA) and Farmville Feeling a 'Drought' of Their Own

Zynga (Nasdaq: ZNGA) and Farmville Feeling a 'Drought' of Their OwnTomahawk, WI 7/26/12 (StreetBeat) – Zynga (Nasdaq: ZNGA) is having a terrible pre-market day this morning down more than 40 percent at $3.04 per share on volume of more than 4.5 million shares, as I write.

Many analysts slashed their ratings and price targets after Facebook (Nasdaq: FB) changed the way users find games on its platform. They essentially made it harder to find older games like “FarmVille” and “Hidden Chronicles” that Zynga relies on heavily to keep its social media ship afloat.

Zynga is down more than 60 percent since March and has a range between $4.45 and $15.91 per share. Market cap is $3.75 billion and Zynga averages just fewer than 24 million shares traded per day.

This doesn’t look pretty for Facebook, who is slated to report its second quarter earnings after the market close today.

StreetBeat Disclaimer

Distributed by Viestly

Zynga (Nasdaq: ZNGA) and Farmville Feeling a 'Drought' of Their Own

Zynga (Nasdaq: ZNGA) and Farmville Feeling a 'Drought' of Their OwnTomahawk, WI 7/26/12 (StreetBeat) – Zynga (Nasdaq: ZNGA) is having a terrible pre-market day this morning down more than 40 percent at $3.04 per share on volume of more than 4.5 million shares, as I write.

Many analysts slashed their ratings and price targets after Facebook (Nasdaq: FB) changed the way users find games on its platform. They essentially made it harder to find older games like “FarmVille” and “Hidden Chronicles” that Zynga relies on heavily to keep its social media ship afloat.

Zynga is down more than 60 percent since March and has a range between $4.45 and $15.91 per share. Market cap is $3.75 billion and Zynga averages just fewer than 24 million shares traded per day.

This doesn’t look pretty for Facebook, who is slated to report its second quarter earnings after the market close today.

StreetBeat Disclaimer

Distributed by Viestly

Facebook (Nasdaq: FB) Banking on Subscribers Not Financials

Facebook (Nasdaq: FB) Banking on Subscribers Not FinancialsTomahawk, WI 7/26/12 (StreetBeat) – Facebook (Nasdaq: FB) is due to report its much anticipated earnings after the market close today. This is a stock that will be a long-term investment and is not dependent nearly as much as most every other stock on its earnings and revenue numbers as opposed to its number of subscribers.

Facebook is, by far, the most popular social network after surpassing MySpace years ago with its user-friendly apps and popular games but has frustrated investors and potential investors by not taking advantage of the potential revenue from its subscriber base of a billion plus.

The stock is a heavily traded stock, averaging more than 46 million shares per day, with a range between $25.52 and $45.00 since its IPO back in May.

Currently, Facebook has a market cap of $63 billion and closed yesterday at $29.34 per share.

In pre-market trading, shares were down more than 6 percent at $27.50 per share with traders expecting disappointing results.

Estimates are calling for earnings of $0.12 per share on revenue of $1.15 billion.

StreetBeat Disclaimer

Distributed by Viestly

Wednesday, July 25, 2012

Apple (Nasdaq: AAPL) Its a Swing and a Miss

Northern, WI 7/25/2012 (StreetBeat) -- Apple takes a swing and missed margins on the iPad pushing shares prices considerably lower in morning trading. Where and when will the bleeding stop? See Full Disclaimer

Distributed by Viestly

Record Quarter for Caterpillar (NYSE: CAT): Up 4% in Pre-Market Trading

Record Quarter for Caterpillar (NYSE: CAT): Up 4% in Pre-Market TradingTomahawk, WI 7/25/12 (StreetBeat) – Caterpillar (NYSE: CAT) reported record results for its second quarter and beat estimates by a large margin this morning sending the stock up more than 4% in pre-market trading.

Caterpillar cited strong global sales of its construction and mining equipment as the main reason for its record quarter, so the company also raised its guidance for the year.

Net Income was $1.7 billion, or $2.54 per share, in the second quarter, which is up from $1.02 billion, or $1.52 per share, a year ago.

Revenue increased 22 percent to $17.37 billion from last year’s $14.23 billion.

Estimates were for EPS of $2.28 on revenue of $16.98 billion.

As for the company’s outlook, Caterpillar now projects EPS of $9.60, which is up from its projection of $9.50 back in April, but Caterpillar lowered its revenue projection for the year.

StreetBeat Disclaimer

Distributed by Viestly

Tuesday, July 24, 2012

Netflix (Nasdaq:NFLX) Beats Estimates But Lowers Outlook: Aftermarket -15%

Netflix (Nasdaq:NFLX) Beats Estimates But Lowers Outlook: Aftermarket -15%Tomahawk, WI 7/24/12 (StreetBeat) -- Netflix (Nasdaq: NFLX) beat analysts' EPS estimates by more than double but lowered their guidance. This was blood in the water for sellers driving share price down more than 15 percent in aftermarket trading. As I write, shares of Netflix were at $68.80 per share after closing the day up slightly at $80.39 per share.
For the second-quarter, Netflix reported earnings of $0.11 a share on revenue of $889.2 million. Estimates were for earnings of $0.05 a share on revenue of $888.9 million.

A year ago, the company earned $1.11 a share on revenue of $788.6 million.
Netflix projected a weak third-quarter forecast, with results in a range between a loss of ($0.10) a share to a profit of $0.14 a share. Estimates are for earnings of $0.11 a share.

Sarepta Therapeutics (NASDAQ: SRPT) has Big News

Northern, WI 7/ 24/ 2012 (TheStreetBeat) - Sarepta Therapeutics (NASDAQ: SRPT) stock is up over 130% in morning trading following the results from a small study of their drug eteplirsen. See Full Disclaimer

Distributed by Viestly

Monday, July 23, 2012

What is the True Value of Water

What is the True Value of WaterTomahawk, WI 7/23/12 (StreetBeat) – Bottled water is a $10 billion industry and in a year like this one with the record drought affecting much of the US corn market, water has been a hot topic between politicians, analysts, farmers and, of course, the everyday consumer.

I grew up on a cotton farm in Mississippi and have spent many a hot summer days pumping millions of gallons of water into the fields with nothing on my mind but how hot it was outside.

Today, I watched a special on CNBC about the business of water entitled “Liquid Assets” and began to reflect on how much water is wasted everyday which is one of the main reasons why there is so much more of a push today on conservation.

Water is the most abundant resource on the planet, but it, like anything else can be depleted unless people take the proactive approach of using only what they need instead of wasting countless gallons on the overwatering of gardens, lawns, houseplants, etc…

The “Liquid Assets” special was a very informative and interesting piece that everyone in the world, especially the US, can relate too.

Should water be more regulated? How much water does the average person really need and how is that determined? What should a farmer receive per acre to water his/her crops on an annual basis?

These are just a few of the questions that would have to be answered before drafting new legislation or drawing up a realistic plan to actively approach water conservation.

Some water stocks to follow:

Mueller Water Products (NYSE: MWA) closed up slightly at $3.51 per share on moderate volume.

Aqua America (NYSE: WTR) closed down at $26.54 per share on average volume.

Abtech Holdings (OTC: ABHD) closed down slightly at $0.82 per share on light volume.

StreetBeat Disclaimer

Distributed by Viestly

Galectin Therapeutics (GALT) is up over 70%

Northern, WI 7/ 23/ 2012 (TheStreetBeat) -- Galectin Therapeutics (NASD:GALT): has been issued a new patent in their ongoing treatment of liver disease. This has sent their share price up over 70% in morning trading. Full Disclaimer Here

Distributed by Viestly

LargeCap Stocks to Watch Today

LargeCap Stocks to Watch TodayTomahawk, WI 7/23/12 (StreetBeat) -- McDonald's (MCD), the fast-food giant, is expected by analysts Monday to post second-quarter profit of $1.38 a share on sales of $6.94 billion.

Germany's Bayer and Onyx Pharmaceuticals (ONXX) said Monday that Tarceva, a jointly produced drug, in combination with Nexavar tablets for the treatment of hepatocellular carcinoma, a type of liver cancer, failed in further improvement of overall survival.

NRG Energy NRG said Sunday it reached a deal to buy GenOn Energy (GEN) for $1.7 billion in stock.

The merger creates the largest U.S. independent power producer.

Halliburton (HAL) is expected by analysts Monday to post second-quarter earnings of 75 cents a share on revenue of $6.93 billion.

Chipmaker Texas Instruments (TXN), according to analysts, will post second-quarter profit of 41 cents a share on revenue of $3.35 billion.

Texas Instruments posts numbers after Monday's closing bell.

Hasbro (HAS), the toy maker, is seen by analysts posting quarterly earnings on Monday of 24 cents a share on revenue of $832 million.

StreetBeat Disclaimer

Distributed by Viestly

Friday, July 20, 2012

Pluristem Therapeutics Inc. is Up Over 15%

Northern, WI 7/20/12 (traderscorner) -- Pluristem Therapeutics Inc.. (NASDAQ: PSTI) is a stem Cell research company that is on the move. Their share price is up over 15% in morning trading. See Disclaimer Here

Distributed by Viestly

Kayak and Palo Alto Take Off Day One Trading with a Bang

Kayak and Palo Alto Take Off Day One Trading with a BangPalm Beach, FL 7/20/12 (StreetBeat) – Kayak (Nasdaq: KYAK), a household name for online hotel-and flight-search, jumped $4, or 16 percent, this morning to open at $30 a share.

The company sold shares last night at $26 a share, raising $100 million. At that price point, the company has a market valuation of $1 billion.

Only last week, Kayak had estimated it would sell 3.5 million shares between $22 and $25. The stock can be found on Nasdaq Exchange under the ticker symbol “KYAK.”

Kayak was founded in 2004 by Steve Hafner, Kayak’s CEO, and Paul English, Kayak’s CTO.

The IPO has been a long time in coming. The Norwalk, Conn.-based company filed nearly a year ago, but faced multiple delays as the economy sputtered. More recently, the offering was considered to be a possibility again after other companies, such as LinkedIn, Yelp, Angie’s List, Facebook and others, went public with varying degrees of success.

Palo Alto Networks (NYSE: PANW), a provider of Internet firewall technology, also started trading early this morning, jumping as much as 48 percent in its public debut.

Kayak had raised a combined $223 million over four rounds, including a mammoth $196 million round in 2007 from Sequoia Capital, General Catalyst Partners and Accel Partners, most of which was used to acquire rival SideStep for about $200 million in cash and stock.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Rambus Inc (Nasdaq: RMBS) Drops 15% After Q2 Report

Rambus Inc (Nasdaq: RMBS) Drops 15% After Q2 ReportOrlando, FL 7/20/12 (StreetBeat) – Rambus Inc. (Nasdaq: RMBS) missed Wall Street’s earnings targets by $.09 per share in its Q2 report, causing shares to plunge 15% to $4.43. The stock has dropped 37% in 2012, and the company cites 15% lower sales year over year on “decrease in contract revenue, lower royalties reported by certain licensees and expiration of a patent license agreement.”

According to Motley Fool, the company is spending less on expensive litigation campaigns than it used to, but operating costs are way up anyhow. This it due to Rambus’ trying its hand at growth by acquisition, incurring a variety of costs for the add-on operations. Rambus received its first royalty payment from a recent Broadcom agreement, but it wasn’t enough to balance out Rambus’ challenges.

Rambus is currently a one-star CAPs stock (out of five). The company plans to explore pathways such as its new LED lighting research, hoping for about 15% of its revenue out of that division in 2013.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Chipotle Mexican Grill (NYSE: CMG) Plunges on Slowing Sales

Chipotle Mexican Grill (NYSE: CMG) Plunges on Slowing SalesNorthern, WI 7/20/12 (StreetBeat) – Chipotle Mexican Grill (NYSE: CMG) is the biggest loser on the NYSE, with shares trading down 22.6% after touching a low of $309.01 in morning trade. It lost almost a quarter of its market value Friday after announcing a slower sales growth in Q2.

"We continue to worry about slower growth in the second half of 2012 (in the absence of) additional menu pricing, acceleration in multiyear traffic trends, or a positive margin surprise," BMO Capital Markets analyst Phillip Juhan, who cut his target price to $410 from $440, wrote in a client note.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Onyx (Nasdaq: ONXX) Trading Higher After Rival Drug Fails Test

Onyx (Nasdaq: ONXX) Trading Higher After Rival Drug Fails TestNorthern, WI 7/20/12 (StreetBeat) – Onyx (Nasdaq: ONXX) shares hit a 52 week high in trading Friday after announcing that its competitor’s drug trials failed to demonstrate statistically significant results on the study. Bristol-Meyers (NYSE: BMY) reported last night that its brivanib, a liver cancer treatment, failed to meet its primary overall survival objective in a Phase III Trial. Onyx’s Nexavar is used to treat liver cancer, and CEO Leerink Swann wrote that brivanib’s failure represents a significant positive for the long-term outlook of Nexavar.

Onyx increased 6% in morning trade Friday, up $4.10 to $72.50. Bristol Meyers decreased 1.75% to $35.51 after reporting these results.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Baker Hughes (NYSE: BHI) +10% After Global Oilfield Growth

Baker Hughes (NYSE: BHI) +10% After Global Oilfield GrowthShawshank, VA 7/20/12 (StreetBeat) – Schlumberger Ltd (NYSE:SLB) and Baker Hughes Inc (NYSE:BHI) reported higher-than-expected profits on Friday as revenue significantly increased outside North America. Shares of Baker Hughes shot up 10% after releasing this news.

In June, Baker’s rig count outside North America hit its highest level since 1985 at 1,285 rigs. Schlumberger and Baker, the world’s #1 and #3 oilfield service companies, were enthused by the return of the Gulf of Mexico drilling levels seen before the disastrous spill 2 years ago.

"We are also realizing price improvements as activity ramps up," Baker Hughes Chief Executive Martin Craighead said.

Baker forecasts 8% growth in the international count this year and Schlumberger expects more than 10% growth. Shares of Baker are trading up 10% or $4.29 at $46.04. Schlumberger has increased 2% to $70.01.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

EcoloCap (OTCBB: ECOS) Signs Non-Binding LOI with GFE Global

EcoloCap (OTCBB: ECOS) Signs Non-Binding LOI with GFE GlobalShawshank, VA 7/20/12 (StreetBeat) – EcoloCap Solutions Inc (OTCBB: ECOS) has signed a non-binding LOI with GFE global Inc to operate and distribute its diesel water emulsion (M-Fuel) production NPUs as well as its proprietary additive. This LOI is subject to further discussion and definitive agreements are expected to be signed by July 25, 2012. In this deal, EcoloCap’s M-Fuel products will be sold in Central American countries as a first step, and then extend to other areas based on penetration targets.

Michael Siegel, President and CEO of EcoloCap, stated: "Central America is a prime target for our technology for two reasons: The high cost of fuel in the area and government environmental regulations for heavy oil users to reduce harmful emissions. Independent tests demonstrate that our M-Fuel technology will reduce the consumption of diesel and other heavy oil by up to 30% and further reduce particulate emissions by over 90%, and NOx by 60%."

Joseph J Black, COO of GFE Global Inc., added: "All Latin American counties with the exception of Venezuela and possibly Brazil are petro fuel NET importers. Many have no oil resources whatsoever. The cost of diesel fuel is well over $4 a gallon in most of these countries and over $5 a gallon in several. We will start introducing the EcoloCap technology in Costa Rica because of their high priced fuel and the government's goal for the country to be carbon neutral by 2021, Costa Rica being true to their reputation as an eco-oriented country. We then plan to expand to Panama and other Latin American countries.”

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

IDO Security (OTCBB: IDOI) Installs Additional Units in Israeli Government Offices

IDO Security (OTCBB: IDOI) Installs Additional Units in Israeli Government OfficesAtlanta, GA 7/20/12 (StreetBeat) – IDO Security Inc (OTCBB: IDOI) announced yesterday that it has installed additional MagShoe™ systems in government offices throughout Israel. The company develops the innovative MagShoe shoe scanning device with proprietary technology to close the security gap created by the inability of traditional walkthrough metal detectors to scan the area below the knee. This order is a follow-up to successful installation of the MagShoe in 2007 at other Israeli government buildings in Jerusalem, still in use today.

Avishai Rotshtain, IDO Security's Marketing Manager commented, "This order is a vote of confidence by the Israeli security establishment in the MagShoe as a tool of choice to detect metallic objects in lower parts of the body. It is a confirmation of a long and ongoing relationship between Israeli security officials and IDO. The MagShoe's increased presence in Israel's airport and government facilities signify a strong foothold in the country and we hope to see continued success as we further build upon our relationship as we look to expand into other markets including loss prevention."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Know Before Trading

3 Things to Know Before TradingAtlanta, GA 7/20/12 (StreetBeat) – Stocks were mostly weaker in Asian trade. The Nikkei was among the worst with a 1.4% loss, Shanghai was down three quarters of a percent and Australia lost a slight fraction. The Hang Seng stood out with a gain of 0.4%. European indexes are down this morning, with the Dax and Footsie both down a bit more than a half percent. US stock futures are lower by a half percent or so as I write.

*Euro Zone Fin Mins completed the agreement on Spain’s bank bailout during a Euro Group conference call today.

*Maybe the Euro Group can schedule another conference call to discuss not Spain’s banks, but Spain’s regional governments; Reuters is reporting that Spain’s Valencia region says it will seek central government help in repaying its debt.

*None of this is helping the euro currency, today it has set record lows against the Aussie and Loonie and it is not far from the two year low against the greenback that was hit a week ago.

*The June reading of Germany’s Producer Price Index is -0.4%, twice the expected monthly decline. The annualized PPI is +1.6%, also a couple of tenths under the estimate and down five tenths from the level seen in May.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Thursday, July 19, 2012

Sunshine Biopharma (OTCBB: SBFM) Trades up over 10% on News of Manufacturing Adva-27a

Sunshine Biopharma (OTCBB: SBFM) Trades up over 10% on News of Manufacturing Adva-27aAtlanta, GA 7/19/12 (StreetBeat) – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Sunshine Biopharma Inc. (OTCBB: SBFM). The stock is trading up over 10% on news of manufacturing Adva-27a.

The Company reported that it has engaged Beta Pharma Canada Inc. to manufacture an initial batch of Adva-27a and provide synthesis parameters for future scale-up and large scale manufacturing of the drug. Beta Pharma Canada Inc. is an affiliate of Beta Pharma Inc. with offices and facilities in Connecticut (USA) and Shanghai ( China). Beta Pharma Canada Inc., headquartered in Montreal ( Canada), is a Canadian small-molecule drug discovery and manufacturing company specializing in design, synthesis and process development of novel pharmaceutical compounds. Adva-27a is Sunshine Biopharma’s lead anti-cancer compound which has proven effective at killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR).

Recent Q&A with Mr. Camille Sebaaly, CFO of Sunshine Biopharma Inc. (OTCBB: SBFM) at Investorideas.com
http://www.investorideas.com/CO/SBFM/news/2012/07021.asp

About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company’s lead compound, Adva-27a targets aggressive forms of cancer.
www.sunshinebiopharma.com

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas: www.biotechindustrystocks.com

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated Investorideas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26th

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

800-665-0411 - Source – www.Investorideas.com

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Psivida Corp. (PSDV) Skips to Late Stage Trials

Northern, WI 7/19/12 (traderscorner) -- Psivida Corp. (NASDAQ: PSDV) was cleared by regulators to skip initial studies and proceed directly to late stage trials with their new eye insert. This send the share price up over 55% in morning trading. See Disclaimer Here

Distributed by Viestly

Tim Participações (NYSE: TSU) Blindsided with the Blockage of Sales in 19 States

Tim Participações (NYSE: TSU) Blindsided with the Blockage of Sales in 19 StatesAtlanta, GA 7/19/12 (StreetBeat) – TIM Participações SA (NYSE: TSU) was blindsided today with Anatel blocking the sale of new lines in 19 states. Tim is the only operator in today’s market that sells its phones unlocked and without loyalty penalty. In 2011, the company became the 2nd largest mobile operator in the country.

Tim said, "The decision was apparently based on data and indicators different from those usually established by Anatel it self to track the performance of the network. The presented measure took into account, for example, the percentage difference in each state between the worst operator and the others' average in complaints to the Anatel's call center, a measure until now unknown and does not necessarily reflect the quality of the network...TIM reaffirms that it is developing a set of infrastructure projects to continue to provide innovative services to customers, supporting the growth and capturing the opportunities that market offers...The Company is also working on upgrading equipment, doubling the speed of the infrastructure of mobile Internet access to 42 Mbps, or HSPA+, an intermediate step between 3G and 4G."

Shares are trading down 8% or $2.08 at $21.65 Thursday.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Five Below (Nasdaq: FIVE) Trading +55% on IPO Debut

Five Below (Nasdaq: FIVE) Trading +55% on IPO DebutShawshank, VA 7/19/12 (StreetBeat) – Five Below (Nasdaq: FIVE) pops 55% in its IPO debut on the Nasdaq today. The company priced its IPO at $17, the top of its IPO price range, and is currently trading at $26.44.

9.6 million shares are being sold in this IPO, split between the company and shareholders. The underwriters include Goldman Sachs, Barclays, and Jefferies.

The Wall Street Journal comments on IPOS this year that this will help “the already high average for first-day IPO pops seen this year and set a high bar for a list of other IPOs coming this week, including long awaited Kayak Software and Palo Alto Networks. Palo Alto also boosted its price range this week.”

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Psivida Corp (Nasdaq: PSDV) Soars As Eye Device Moves to Late-Stage Trials

Psivida Corp (Nasdaq: PSDV) Soars As Eye Device Moves to Late-Stage TrialsPalm Beach, FL 7/19/12 (StreetBeat) – Shares of Psivida Corp (Nasdaq: PSDV) surged 37% Thursday following the U.S. health regulators clearance of its experimental eye insert to skip initial studies and proceed directly to late-stage trials. The insert is a sustained-release device injected into the back of the eye and aims to treat posterior uveitis. Posterior Uveitis, classified as the 3rd largest cause of blindness in the US, is an inflammatory disease of one of the layers of the eye.

"As the same micro-insert was used in the Iluvien trials, we expect to observe a comparable side-effect profile in uveitis patients as was seen in diabetic macular edema patients," Chief Executive Paul Ashton said. Iluvien has been rejected twice by the FDA, but is currently approved to treat retinal swelling in diabetic patients in the UK, Austria, France, and Portugal.

Psivida added that “since the experimental insert delivers the same drug as its other insert Retisert, which is FDA-approved to treat posterior uveitis, the company expects to see favorable efficacy in the late-stage studies”.

Shares are currently trading at $2.94, up $.80 or 37%.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Pool Corp (Nasdaq: POOL) Cut Forecast, shares Down 11%

Pool Corp (Nasdaq: POOL) Cut Forecast, shares Down 11%Palm Beach, FL 7/19/12 (StreetBeat) – Pool Corp (Nasdaq: POOL) shares are trading down 11% after posting lower- than-expected quarterly results. The swimming pool distributor cites pricing pressures and unfavorable changes in customer mix for this decline. The company cut its upper end fiscal 2012 earnings forecast from $1.85 to $1.82 per share.

Net Income Q2 rose to $64.9 million ($1.34 per share) from $58.6 million ($1.19 per share) a year earlier. Revenue rose 7% to $757.2 million. According to Thomson Reuters, analysts were expecting earnings of $1.35 per share on $770.1 million.

Pool Corp’s stock touched a low of $36 in early trading, currently trading at down $3.35 at $37.17.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Georgia Gulf (NYSE: GGC) Getting PPG Unit in $2 Bill Deal

Georgia Gulf (NYSE: GGC) Getting PPG Unit in $2 Bill DealOrlando, FL 7/19/12 (StreetBeat) – Shares of Georgia Gulf (NYSE:GGC) are trading up 14% this morning after reaching a deal for a merger with PPG Industries (NYSE:PPG), giving it a large stake and control in a newly formed chemicals player. PPG Industries plans to spinoff its chemicals operations and merge it with Georgia Gulf, with PPG shareholders getting 50.%% and Georgia Gulf will have 49.5%.

Earlier this year, Georgia fought off a hostile takeover attempt from rival Westlake Chemical, saying that it was doing just fine and the $35 offer price wasn’t fair. The transaction between Georgia Gulf and PPG is worth $2.1 billion, with PPG getting $900 million in cash and $1 billion in shares of Georgia Gulf. The combined company will have about $5 billion in annual revenues and be the #3 producer in North America of chlor-alkali, a chemical used in chlorine, PVC piping, and other uses.

Georgia Gulf shares jumped 14% to $33.04 in trading Thursday while PPG added 7% to $111.63.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Mellanox Tech (OTCBB:MLNX) Hits Lifetime High in Morning Trade

Mellanox Tech (OTCBB:MLNX) Hits Lifetime High in Morning TradeNorthern, WI 7/19/12 (StreetBeat) – Mellanox Technologies Inc (OTCBB: MLNX) reached its lifetime high in trading today after announcing an impressive quarterly profit that beat analyst expectations. At least 10 brokerages raised their price targets on the company’s stock, with Harel Finance analyst Rami Rozen stating “this is the second quarter in a row that Mellanox breaks every growth record possible and raises the level of investors’ expectations to new heights.”

Mellanox designs chips for the InfiniBand data exchange standard that regulates the way servers and data systems communicate with each other. Its quarterly growth can be contributed to the strong storage, data, and cloud trends we are seeing today. "In InfiniBand (IB), Mellanox is a generation ahead of Intel Corp (INTC) and clearly benefiting from IB gaining share in various servers/storage platforms," Needham & Co wrote in a note. Its clientele include big names such as Hewlett-Packard Co (NYSE: HPQ) and IBM Corp (NYSE: IBM).

Shares of the company increased 36.73% this morning, trading up $24.38 at $90.76. The company has seen its stock more than double in the past year alone.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Emrise (OTCBB: EMRI) Receives $1.5 Million Electronic Devices Order

Emrise (OTCBB: EMRI) Receives $1.5 Million Electronic Devices OrderNorthern, WI 7/19/12 (StreetBeat) – Emrise Coroporation (OTCBB:EMRI) announced yesterday that it received a $1.5 million order for its products to be used throughout commercial aircrafts’ In-Flight Entertainment and Connectivity (IFE&C) systems. The company will provide electronic devices and subsystems for the IFE&C systems, following a recent $5.4 million order and increasing the total value of major IFE&C electronic device orders to more than $8 million booked to date in 2012. This order is from a longstanding customer and will have shipments starting in this year’s fourth quarter and continue through 2014

The demand for these advanced IFE&C systems have continually increased with the desire for new technologies. They can deliver to the passenger seay a variety of multimedia entertainment features including live satellite TV and a number of connectivity features such as GSM for in-flight mobile phone use and Broadband for access to Internet, e-mail, and messaging services. Emrise has been seeing ongoing grown in this IFE&C market, and CEO Carmine Oliva noted that the number of orders is up approximately 144% from the comparable period in 2011.

"Today we are selling electronic devices to an increasing number of customers in the IFE&C market," Oliva said. "This larger and more diverse customer base further opens up the IFE&C market potential for the Company, which is also contributing to our growing backlog of orders."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Know Before Trading

3 Things to Know Before TradingNorthern, WI 7/19/12 (StreetBeat) – Stocks were mostly higher in Asian trade. Australia was among the best with a gain of two percent, the Hang Seng added one and two thirds percent, the Nikkei was up 0.8% and Shanghai rose 0.7%. European indexes are higher this morning, with the Dax better by one percent and the Footsie up a half of a percent. US stock futures are up by almost a half percent as I write.

*The May reading of Japan’s All Industry Activity Index is -0.3% on a month on month basis, as expected.

*The June reading of Japan’s Nationwide Department Store Sales were -1.2% year on year; the weakest result of the year.

*The June reading of Switzerland’s Trade Balance is a surplus of SF2.25 billion, down from a surplus of SF2.52 billion the month before. Exports were down 2.6% month on month and Imports were lower by 3.1% from the month before.

*The June reading of UK Retail Sales is +0.1% month on month, well short of the estimate of +0.6%.

*Germany’s Bundestag vote on the Spanish bailout is set for today, as it is in Finland; both votes are expected to pass. In regards to Spanish aid, there is a story in the WSJ that says EFSF funds will be used to buy Spanish debt, which is a strategy that could bring a Moody’s downgrade to junk because it would indicate the country has lost access to the private debt markets. An EC spokesman denies the story. Additionally, the Italian Parliament has approved the ESM in a vote this morning.

*Morgan Stanley is among the companies that are reporting on earnings today. MS missed the estimate by a considerable amount with an adjusted eps of 16 cents versus 29 cents expected.

*The weekly report on Initial Jobless Claims is due out at 7:30am CDT, it is expected to be 365k. The July reading of the Philly Fed Business Activity Index is due out at 9:00am CDT, it is forecast to be -8.0, up from -16.6 the month before. There are a couple of more bits of data that are also due out at 9:00am: the June reading Existing Home Sales, expected to be 4.62 million units annualized or up 1.5% on the month; and the June reading of the Leading Economic Indicators, estimated to be -0.1% on the month.

*The weekly report on inventories of Natural Gas is due out at 9:30am CDT, it is expected to show an increase of 33 bcf.

*The Fed is scheduled to buy Treasuries today that are due to mature between 2/15/36 and 5/15/42; the results of the operation will be announced just after 10:00am CDT.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Wednesday, July 18, 2012

EncounterCare Solutions (OTCBB: ECSL) Forms New Subsisidary

EncounterCare Solutions (OTCBB: ECSL) Forms New SubsisidaryNorthern, WI 7/18/12 (StreetBeat) – EncounterCare Solutions Inc (OTCBB:ECSL) has formed a new subsidiary Cyber Fuels, Inc, and has also partnered for addiction recovery treatment. With the Cyber Fuel news, EncounterCare plans on having it focus on managing new market initiatives in energy. Energy will be a major part of EncounterCare’s business plan in this fiscal year, and this new subsidiary provides an exciting opportunity for success in this area. The addition of Cyber Fuels, Inc. marks EncounterCare Solutions, Inc.'s entrance into the field of alternative fuels and is the parent companies third market of business.

One of EncounterCare’s other subsidiaries, CyberCare Health Network, has announced its arrangement with Addiction Reach, Inc to begin marketing its new Alcohol and Drug Addiction monitoring program in October. This program is an integral part of CyberCare’s therapy program for at home concierge addiction recovery treatment. The program will be debuted at the “MOMENT OF CHANGE” annual conference on October 7, 2012 at the Breakers Hotel in Palm Beach, FL.

Sue Merklin, President of Addiction Reach Inc., stated, "Patient monitoring and accountability is essential for long term addiction recovery."

EncounterCare Solutions Inc is trading up 9.38% at $0.35 Midday Wednesday.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

mPhase (OTCBB: XDSL) to Partner with Stevens IT on Research and Business Opportunities

mPhase (OTCBB: XDSL) to Partner with Stevens IT on Research and Business OpportunitiesAtlanta, GA 7/18/12 (StreetBeat) – mPhase Technologies Inc (OTCBB:XDSL) and Stevens Institute of Technology have jointly agreed to pursue business opportunities with government and industry as well as research and development projects. The companies will focus on the design and fabrication of an advanced battery technology utilizing intellectual property and resources from both parties. They plan to try to advance mPhase’s Smart NanoBattery Technology with Steven’s graphene-based inkjet printing method for printing electrodes and electronic circuits.

"mPhase is excited to explore the possibilities of integrating Stevens' leading position in the inkjet printing of energy storage devices using graphene with mPhase's Smart NanoBattery Technology," said Ronald A. Durando, CEO of mPhase Technologies.

"Stevens looks forward to continuing its relationship with mPhase by pursuing this exciting opportunity," added Christos Christodoulatos, Associate Provost of Stevens, Office of Academic Entrepreneurship.

mPhase Technologies is trading up 5.88% Wednesday.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Vivus Inc (NasdaqL VVUS) Gets FDA Approval on Weight Loss Drug

Vivus Inc (NasdaqL VVUS) Gets FDA Approval on Weight Loss DrugAtlanta, GA 7/18/12 (StreetBeat) – Vivus Inc (Nasdaq: VVUS) is trading up 13.6% or $3.60 at $30.06 following FDA approval of its one a day weight loss drug, Qsymia.

Vivus is a biopharmaceutical company focusing its studies in obesity, sleep apnea, diabetes, and sexual health. The Qsymia drug, with an expected fourth quarter 2012 release, is the first drug of its kind to be approved by the FDA.

"Qsymia is the first FDA-approved once daily combination treatment for patients struggling with obesity," said Peter Tam, president of Vivus in a prepared statement. "The degree and severity of obesity and the lack of effective pharmacological interventions that we face as a society were two primary reasons for the development of Qsymia. We are pleased with FDA's decision today because patients and physicians now have another treatment option available to them."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Rovi Corp (Nasdaq: ROVI) Shares Crash on Weak Forecast

Rovi Corp (Nasdaq: ROVI) Shares Crash on Weak ForecastShawshank, VA 7/18/12 (StreetBeat) – Rovi Corp (Nasdaq: ROVI) has released a bleak forecast for the year ahead. The company estimates 2Q results below analyst expectations and its cut forecast comes form an anticipated weakening of sales in its consumer electronics division. Two brokerages have downgraded its stock as a result, and Rovi shares have, consequently, slumped 35% today. Rovi’s shares were down $6.10 at $11.50, making them the top percentage loser on the Nasdaq Wednesday morning.

Electronics Manufacturers such as Apple Inc and Sony Corp use Rovi’s software to play various digital media formats on home entertainment devices. Rovi has been affected by the weakening demand for devices that use its technology and a slow pace of license renewals and sales.

"Rovi has not executed effectively recently and is now, in our view, facing uncertainty surrounding the timing of new license agreements as well as weakness in its underlying market," BMO Capital Markets analyst Edward Williams wrote in a note to clients.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Galena Bio (Nasdaq: GALE) +20% on U.S. Patent Issuance

Galena Bio (Nasdaq: GALE) +20% on U.S. Patent IssuanceShawshank, VA 7/18/12 (StreetBeat) – Galena Biopharma Inc (Nasdaq:GALE) has been issued a key patent from the U.S. Patent and Trademark Office (USPTO) covering the use of its product candidate, NeuVaxTM, for inducing immunity to breast cancer recurrence in patients having low-to-intermediate IHC levels of 1+ or 2+ and a FISH rating of less than 2.0. This patent strengthens NeuVax’s Intellectual Property and provides the company with exclusivity until 2028. As much as 80% of breast cancer patients who do not qualify for Herceptin ® Therapy represent a significant unmet medial need, of which NeuVax is trying to fulfill.

"As we continue to make progress with the clinical development of NeuVax, issuance of this patent from the USPTO underscores our commitment to support and advance our proprietary oncology pipeline," stated Mark J. Ahn, Ph.D., President and CEO.

Gale's stock has surged 20% following this news, up 35 cents to $2.06.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Amphenol Corp (NYSE: APH) Beats Analyst Expectations, Shares Up

Amphenol Corp (NYSE: APH) Beats Analyst Expectations, Shares UpPalm Beach, FL 7/18/12 (StreetBeat) – Amphenol Corp (NYSE: APH) is trading up today after its quarterly profit beat analysts’ expectations and it raised its full-year forecast for the second time. The electronic connector maker cites this optimistic forecast with a surge in high technology applications across its markets is expected to boost demand.

Amphenol has raised its per-share year earnings forecast from $3.30 to $3.38 to between $3.38 and $3.44 per share. The company projects full-year revenue of $4.21 billion to $4.25 billion, up from its prior $4.11 billion to $4.19 billion forecast.

For the 2nd quarter, APH beat analyst expectations of earnings of 84 cents per share on revenue of $1.05 billion with reporting actual earnings of $140.9 million, or 86 cents per share. Revenue rose 4% to $1.06 billion.

Amphenol’s shares are trading up $5.54 at $56.90, increasing 10.79% upon market open.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Soligenix (OTCBB: SGNX) Awarded $600,000 Small Business Innovation Grant

Soligenix (OTCBB: SGNX) Awarded $600,000 Small Business Innovation GrantPalm Beach, FL 7/18/12 (StreetBeat) – Soligenix Inc (OTCBB:SNGX) has been awarded a Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases (NIAID). Soligenix is a development stage biopharmaceutical company, and this 2-year $600,000 grant is given to support the preclinical development of its OrbeShieldTM product as a treatment for gastrointestinal acute radiation syndrome (GIARS).

Acute GIARS develops from exposure to high dose radiation following a serious nuclear event. Currently, there’s no effective therapy approved for the treatment of this life-threatening consequence.

"We are encouraged with the promising survival results observed to date with OrbeShield™ in the beagle model as a post-exposure therapy for the treatment of GI ARS," stated Christopher J. Schaber, PhD, President and CEO of Soligenix. "With renewed support from NIAID, we look forward to working with Dr. Georges to continue development of OrbeShield™ with the aim of addressing this critical unmet medical need."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Suspect Detection Systems (OTCBB: SDSS) Fulfills Order for Additional Cogito Units

Suspect Detection Systems (OTCBB: SDSS) Fulfills Order for Additional Cogito UnitsOrlando, FL 7/18/12 (StreetBeat) -- Suspect Detection Systems Inc. (OTCBB: SDSS), through its subsidiary Suspect Detection Systems Ltd., is a developer of proprietary counter terrorism and crime prevention technology designed to identify threats in real-time, and prevent incidents before they are carried out. The technology detects the hidden "hostile intent" of assailants - before they commit their intended acts - with a high degree of accuracy. The system can also be used after a crime is committed to quickly identify criminals from among a general population pool, including suspects.

In a recent press release, the company has announced that several thousand aviation employees of a major American airline have been screened utilizing the proprietary Cogito hostile intent detection system in Latin America.

The CEO, Mr. Boosidan, also added that "The successful implementation of this screening procedure provides us with opportunities for our proprietary Cogito threat detection system to be used to screen airport employees on multiple continents,"

One of the high profile products offered by the company is called Cogito. It has been designed with both mobile and stand-alone applications. The technology can be instantly introduced to any market, and can be easily deployed worldwide at any location susceptible to infiltration and attack.

Other include Cogito4M - Mobile System
The Mobile System enables Cogito to be employed whenever and wherever it is needed. The mobile functionality allows interrogations to take place in central and remote locations alike. Cogito has been utilized at crime scenes and in even in the middle of war zones.

In many cases, it is easier to transport Cogito to potential suspects, than it is to transport those suspects to an interrogation unit.

The picture displays the Cogito 4M Mobile System unit utilized by military for rapid intelligence gathering in the field, police interrogations, mobile pre-employment screenings, and internal threat and theft prevention applications.

The mobile system is comprised of all of the components of the stand alone system.

Cogito4M - Military Grade Rigid Manpack System
The rigid manpack system allows soldiers to carry Cogito in the field. The Military Grade Rigid Manpack System is even smaller than the typical Mobile 4M unit.

The casings are sturdy and light while the system has all the components of a standalone unit. The system can be used in war zones and across borders.

Cogito 1003 Standalone Mass Screening Unit
The Standalone Mass Screening Unit is ideal for locations where dozens of interrogations will take place each day (ie. airport terminals, border crossings, etc.). In addition, tens of stations can be installed in a single location, or at various locations (across several airport terminals), and monitored by a single administrator.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Know Before Trading

3 Things to Know Before TradingOrlando, FL 7/18/12 (StreetBeat) -- Stocks were mixed in Asian trade. The Hang Seng fell more than one percent, Australia lost 0.4% and the Nikkei was down a third of a percent, but Shanghai rose about a third of a percent. Similar results so far in Europe, with the Dax up a slight fraction and the Footsie essentially unchanged on the session. US stock futures are down about a quarter percent as I write.

*The July reading of Switzerland’s ZEW Survey of Expectations of Economic Growth improved by a point from the month before to -42.5.

*Germany had strong demand at a 2-year Schatz re-opening auction; they sold EU4.173 billion of the paper at a negative 0.06%. The first time Germany has auctioned off one of its bonds at a negative yield.

*German Chancellor Merkel says she is optimistic on this Thursday’s vote in parliament on aid to Spain.

*The Bank of England says the near-term outlook had weakened when they last met to decide on monetary policy, according to the minutes from that meeting and they may reconsider the case for a rate cut after they assess the impact of their QE strategy on the economy.

*The May reading of the UK Unemployment Rate is 8.1%, down one tenth on the month and one tenth under the forecast. However, in June the net change in the number of Jobless Claims was +6.1k, a bit more than expected.

*US mortgage applications were up 16.9% in the week ended July 13, according to the Mortgage Bankers Association. Applications for Refinancing were up 21.6% in the week, but applications for Purchase were down 0.1%.

*Bank of America, Honeywell and Abbott are among the companies reporting their quarterly earnings results today.

*The June reading of Housing Starts is due out at 7:30am CDT. Starts are expected to be 745k on an annualized basis, or up 5.2% from the month before. The estimate for Building Permits is 765k annualized, or down 2.4% from the previous month.

*Bernanke is back on the Hill today at 9:00am CDT to restate his testimony and take questions from the House Financial Services Committee.

*The weekly report on energy inventories is due out at 9:30am CDT. Stocks of Crude Oil are forecast to decline 1.1 million barrels, Gasoline inventories are expected to increase 1.2 million and the estimate for Distillates is also +1.2 million.

*The Fed is scheduled to buy Treasuries today that are due to mature between 8/15/20 and 5/15/22; the results of the operation will be announced just after 10:00am CDT.

*The Fed’s Beige Book is set to be released at 1:00pm CDT.

StreetBeat Disclaimer

Distributed by Viestly

Tuesday, July 17, 2012

CSR (Nasdaq: CSRE) Selling Mobile Phone Chip Unit To Samsung; Stock Soars

CSR (Nasdaq: CSRE) Selling Mobile Phone Chip Unit To Samsung; Stock SoarsOrlando, FL 7/17/12 (StreetBeat) – Chip Maker CSR Plc (Nasdaq: CSRE) announced today its agreement to sell its development operations in handset chips to Samsung for $310 million in cash. This deal includes both the shift of 310 people and 21 U.S. patents to Samsung, which will be licensed back to CSR on a royalty free bases in perpetuity.

The deal, expected to close in Q4, will accretive to EPS in 2013. It will give CSR net proceeds at about $209 million after taxes, restructuring costs and other transaction-related expenses. Samsung will take a 4.9% equity stake in CSR with a $34.4 mil investment.

CSR said the deal will “will transform the profile of CSR’s business and its growth prospects, accelerate its strategy of focusing on high growth markets where it has leadership positions and the ability to deliver differentiated platforms and products, and strengthen earnings per share.”

Five high growth markets CSR will focus on includes Voice & Music, Automotive Infotainment, Indoors Location, Imaging and Bluetooth.

Meanwhile, CSR also said that it expects to report Q2 revenue at the top end of its previous guidance range of $260 million to $280 million. And the company said it is on track to hit consensus revenue estimates for the full year.

CSRE in U.S. trading is up $4.67, or 34.4%, to $18.23.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

RIT Technologies (RITT) is Up 30%

Northern, WI 7/17/12 (traderscorner) -- RIT Technologies, (NASDAQ: RITT) gets independent laboratory approval for the RIT Xlight configurations sending the share price up over 30% in morning trading. See Disclaimer Here

Distributed by Viestly

37 year old Wausau Resident goes from Google to Yahoo CEO

Northern, WI 7/17/12 (traderscorner) -- Yahoo. (NASDAQ: YHOO) announced Marissa Mayer will make the switch from VP at Google to CEO with Yahoo. See Disclaimer Here

Distributed by Viestly

SmallCap Stocks on the Move: SLTD; INAR; MFTH

SmallCap Stocks on the Move: SLTD; INAR; MFTHTomahawk, WI 7/17/12 (StreetBeat) -- Smallcap stocks are usually very volatile and can be great ways to get significant returns without allocating the capital for say an investment in big market names like Microsoft (Nasdaq: MSFT) or Intel (Nasdaq: INTC) that trade in the high dollar ranges.

Solar3D, Inc. (OTCBB: SLTD) was up 2 percent on heavy volume of heavy volume of more than 3 million shares, as I write. SLTD only averages about 112,000 shares traded per day and has a market cap just over $6 million. Solar3D is developing 3D technology to maximize the value of converting sun light into electricity.

InternetArray (PINKSHEET: INAR) is a sub-penny stock and was down 7 percent on heavy volume of more than 15 million shares, as I write. INAR has a market cap just under $2 million and today, launched StockPlay.com, which is the company’s social media site designed for investors focusing on stocks from the OTC markets.

Medisafe 1 Technologies Corp. (OTCBB: MFTH) is also a sub-penny stocks that was down 20 percent on volume of more than 30 million shares, as I write. MFTH has initiated an aggressive share buyback program that should bring it back from the sub-penny realm soon enough. The company is developing an innovative security measure for the administration of drugs via hypodermic needle… In order for the drug to be administered, it must pre-match positively with its intended patient.

StreetBeat Disclaimer

Distributed by Viestly

LiveDeal (Nasdaq: LIVE) CEO Issues Letter to Shareholders

LiveDeal (Nasdaq: LIVE) CEO Issues Letter to ShareholdersNorthern, WI 7/17/12 (StreetBeat) – LiveDeal, Inc. (Nasdaq:LIVE) issued a letter today to shareholders from President and CEO Jon Isaac. The following letter outlines LiveDeal’s recent achievements, strategic business plans and market opportunities for growth.

The stock has plummeted 33% within the past two weeks, currently trading at $9.67. Jon Isaac seeks to provide an explanation and show opportunities of growth through the following letter.

Dear Fellow Shareholders:

I would like to start by saying that I am honored to serve as LiveDeal's President and CEO. Since January of this year, LiveDeal has made tremendous progress, including a significant reorganization of our corporate activities and the development of a new suite of products and solutions to bring to our customers.

First, I'd like to share with you some of our corporate milestones achieved year-to-date:

• We have focused on cleaning up our balance sheet and in the process retired debt with an 18% interest rate. All of the company's assets were secured by this note. I am pleased to announce that this note has been paid in full and our assets have been released from this lender.
• We are now fully compliant with all the requirements pertaining to our Nasdaq listing.
• In addition to relocating offices in Las Vegas, we opened an office in San Diego, California. Combined, we have reduced overhead costs and expenditures to achieve greater operational efficiencies.
• Following 39 consecutive months of losses, I am happy to announce that LiveDeal achieved profitability in the month of April, 2012. This result is based on unaudited financials, and does not predict any future performance of the Company.

The LiveDeal Mission -- To Provide Local Commerce Solutions for Local Businesses Worldwide

Second, I'd like to discuss our mission for the future and the opportunities that we are readily capitalizing on. LiveDeal has a long history of serving local businesses. We wish to remain in this space because we believe there exists tremendous opportunity.

The local commerce segment is estimated to be in the hundreds of billions of dollars. However, in order for us to succeed in the long term, we need to add value for merchants and continue to cultivate our relationships with them. Our business strategy is built around the following:

• Mobile applications will be our primary focus for product development.
• We are developing strategic relationships with larger, well-known companies in the industry that can add value to our local merchant customer base.
• We plan to leverage these strategic relationships and alliances to move quickly to market a suite of state-of-the-art local commerce solutions based on patentable technology.
• We will target our existing subscribers, as well as new customers, for our product line.
• We anticipate to finalize discussions with several large strategic partners, and announce formal agreements with them in the very near future.

LiveDeal: Not a 'Daily-Deal' Company

Third, I want to be clear that LiveDeal is not a "daily deal" company, nor do we have plans to enter into this market segment at this time. Based on our research, we do not believe that the daily deal model is a successful or profitable one. We do not believe that taking 50% of merchants' revenue is a long term value add proposition for our clients. Instead, we have decided to focus on adding value for our merchants. We are in the late stages of releasing a suite of mobile technology applications, which may present ground-breaking solutions to better serve our local business customers. We anticipate that these new products can deliver significant revenue opportunities for our customers.

I believe that we are building a very strong foundation from which our targeted business objectives can be achieved. I hope that you will share in my excitement for LiveDeal's future outlook. I am extremely happy to be part of a company poised for tremendous growth. As always, thank you for your continued support and interest in our Company.

Sincerely,

Jon Isaac
President & CEO
LiveDeal, Inc.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Fuel Tech (Nasdaq: FTEK) Awarded Largest Contract in Its History

Fuel Tech (Nasdaq: FTEK) Awarded Largest Contract in Its HistoryNorthern, WI 7/17/12 (StreetBeat) – Fuel Tech, Inc (Nasdaq: FTEK) was awarded its largest air pollution control contract in its history. The company is trading up 16.19%, increasing 74 cents to $5.31.

Fuel Tech is a leading technology company engaged in the worldwide development, commercialization, and application of state-of-the-art proprietary technologies for air pollution control, process optimization, and advanced engineering services. This $36.6 million order, placed by a major utility in Chile (E.CL S.A.), requires Fuel Tech to use its turnkey installation of Low NOx Burners (LNBs) and Over-Fire Air (OFA) systems and mill modernization for six coal-fired units. Deliveries are expected to commence during the first quarter of 2013, with project completion occurring during the third quarter 2014.

It’s burner technologies are a cost-effective way to reduce NOx emissions and solve combustion problems in coal, gas, or oil combustion systems. Fuel Tech is able to do this by diverting air from the burner zone to the upper furnace for enhanced combustion staging.

“We have consciously expanded our international presence to achieve both growth and regulatory diversification in our air pollution control business. We have strategically focused on key geographic markets and are thrilled to be announcing an order of this magnitude,” commented Douglas G. Bailey, Chairman, President and Chief Executive Officer. “In terms of installed capacity, E.CL S.A. is a major electric generator in Chile and is the main electricity provider in the country’s northern energy grid. In this instance, E.CL is upgrading its combustion systems to reduce NOx emissions below 500 mg/m3 in order to comply with the new Chilean environmental law signed by the President of the Republic of Chile on January 18, 2011. French-Belgian electric company GDF Suez S.A., a global leader in independent power generation, holds a majority controlling stake in E.CL.”

Mr. Bailey concluded, “We are pleased to be partnering with a customer of this size and caliber. This contract award represents our second LNB project in Chile and demonstrates our global reach and combustion capabilities. With our industry-leading suite of air pollution control products and services, we believe we are well positioned to compete for additional opportunities for combustion optimization in the domestic and international markets.”

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly